FDA Drug recall D-0764-2022
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Ad…
- FDA Drug
- Class I
- terminated
- Published 2022-04-13
On 2022-04-13 the FDA classified a Class I recall of SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Ad… by Adamis Pharmaceuticals, citing defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0764-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-03-21 |
| Published | 2022-04-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Adamis Pharmaceuticals |
| Distribution | US |
Product
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.
Reason
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Identifiers
| code_info | Lot # 21101Y, Exp. 11/30/2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0764-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.